Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 9Phase NA 6Phase 2/3 5Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 1Breast 1

Conditions

Tuberous Sclerosis 1Smith-Magenis Syndrome 1Relapsed Malignant Solid Tumor 1Parasomnias 1Breast Neoplasms 1Autism Spectrum Disorder 1Angelman Syndrome 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Melatonin × Clear all
NCT01858155 2019-01-31

Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

C17 Council

Phase 1 Completed
9 enrolled
Other solid neoplasm

Relapsed Malignant Solid Tumor

NCT01903681 2014-04-04

Assessment of the Pharmacokinetics of CircadinĀ® in Children With Neurodevelopmental Disorders and Sleep Disturbances

Neurim Pharmaceuticals Ltd.

Phase 1 Completed
16 enrolled

Autism Spectrum Disorder, Tuberous Sclerosis, Angelman Syndrome, Parasomnias, Smith-Magenis Syndrome

NCT00506064 2012-12-05

Melatonin Postoperative Sleep Study in Breast Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled 2 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔